Articles
NANS Opposes CMS Proposal to Cut Payment for Same-Day E/M Services
Physicians across multiple specialties should be aware of a proposed Medicare payment policy that could…
Proposed Medicare Payment Changes Could Threaten Access to Neuromodulation in Ambulatory Surgery Centers
NANS recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding a…
Congress Moves to Extend Federal Funding Ahead of September Deadline
On August 8, the Senate passed a continuing resolution (CR) that would maintain FY 2026…
CMS Issues Proposed 2027 Medicare Physician Fee Schedule
On July 14, 2026, the Centers for Medicare & Medicaid Services (CMS) released the Calendar…
NANS Strengthens Its Voice in National Health Policy
NANS participated in the 2026 American Medical Association (AMA) House of Delegates Annual Meeting, held…
NANS Urges UnitedHealthcare to Revisit Stroke Therapy Coverage
The North American Neuromodulation Society (NANS) is calling on UnitedHealthcare (UHC) to reconsider its policy denying coverage for implantable vagus nerve stimulation (iVNS) paired with rehabilitation for stroke recovery.
NANS Joins Coalition Urging Action on No Surprises Act Implementation
The North American Neuromodulation Society (NANS) has joined more than 100 medical organizations in a joint letter to federal agencies raising concerns about how the No Surprises Act (NSA) is being implemented.
NANS, Medical Societies Urge Elevance Health to Reconsider PNS Coverage
The North American Neuromodulation Society (NANS), alongside several leading medical societies, recently submitted a joint…
NANS Joins Multisociety Advocacy on Trigger Point Injection Policy
NANS joined a coalition of leading medical societies in submitting formal comment letters to First Coast Service Options and Novitas regarding the proposed LCD for trigger point injections (TPIs).
NANS Applauds Aetna for Revising Policy on Peripheral Electrical Nerve Stimulation for Pain Policy
The North American Neuromodulation Society (NANS) recognizes Aetna for updating its clinical policy on peripheral electrical nerve stimulation (PNS) for pain, expanding access to non-pharmacological treatment options for patients with chronic pain.
NANS Opens Public Comment on Draft PNS Guideline
The North American Neuromodulation Society (NANS) has opened the public comment period for its draft Clinical Guideline on Implantable Peripheral Nerve Stimulation (PNS) for Chronic Pain—one of the first formal guideline initiatives undertaken by the Society.
NANS Joins Multi-Society Effort on PNS Coverage
The North American Neuromodulation Society (NANS) joined several leading medical specialty societies in submitting joint letters to Cigna Healthcare and UnitedHealthcare regarding policies that classify peripheral nerve stimulation (PNS) as investigational for the treatment of chronic pain.